Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis, Anemia, Aplastic, Anemia, Sickle Cell, Autoimmune Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Thalassemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Anemia, Diamond-Blackfan, Renal Insufficiency, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Clinical Trials

BMT

A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia

CAVALRY

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers

NICHE

Weight Gain in Pediatric Leukemia Survivors

Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

CVE-CART

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors

DISCOVERY

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

CD4CAR for CD4+ Leukemia and Lymphoma

Pre-malignant States to Hematologic Malignancies in Firefighters

A Study of Revumenib and Mezigdomide in People With Leukemia

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

BRUOG-407

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL

MAATEO

Bone Marrow Grafting for Leukemia and Lymphoma

QOL-ONE PRO-CT

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

Mosunetuzumab for CLL MRD Clearance

Mature B-Cell Lymphoma And Leukemia Study III

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)